Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

Synthesis and in vitro study of novel neuraminidase inhibitors against avian influenza virus.

Kongkamnerd J, Cappelletti L, Prandi A, Seneci P, Rungrotmongkol T, Jongaroonngamsang N, Rojsitthisak P, Frecer V, Milani A, Cattoli G, Terregino C, Capua I, Beneduce L, Gallotta A, Pengo P, Fassina G, Miertus S, De-Eknamkul W.

Bioorg Med Chem. 2012 Mar 15;20(6):2152-7. doi: 10.1016/j.bmc.2012.01.026. Epub 2012 Jan 26.

PMID:
22342267
2.

A screening assay for neuraminidase inhibitors using neuraminidases N1 and N3 from a baculovirus expression system.

Kongkamnerd J, Milani A, Cattoli G, Terregino C, Capua I, Beneduce L, Gallotta A, Pengo P, Fassina G, Miertus S, De-Eknamkul W.

J Enzyme Inhib Med Chem. 2012 Feb;27(1):5-11. doi: 10.3109/14756366.2011.568415. Epub 2011 Jul 8.

PMID:
21740106
3.

Carbocycles related to oseltamivir as influenza virus group-1-specific neuraminidase inhibitors. Binding to N1 enzymes in the context of virus-like particles.

Mohan S, McAtamney S, Haselhorst T, von Itzstein M, Pinto BM.

J Med Chem. 2010 Oct 28;53(20):7377-91. doi: 10.1021/jm100822f.

PMID:
20873795
4.

Exploitation of the catalytic site and 150 cavity for design of influenza A neuraminidase inhibitors.

Adabala PJ, LeGresley EB, Bance N, Niikura M, Pinto BM.

J Org Chem. 2013 Nov 1;78(21):10867-77. doi: 10.1021/jo401854w. Epub 2013 Oct 16.

PMID:
24090215
5.

Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.

Du QS, Wang SQ, Chou KC.

Biochem Biophys Res Commun. 2007 Oct 19;362(2):525-31. Epub 2007 Aug 13.

PMID:
17707775
6.

Susceptibility of avian influenza viruses of the N6 subtype to the neuraminidase inhibitor oseltamivir.

Stoner TD, Krauss S, Turner JC, Seiler P, Negovetich NJ, Stallknecht DE, Frase S, Govorkova EA, Webster RG.

Antiviral Res. 2012 Mar;93(3):322-9. doi: 10.1016/j.antiviral.2011.12.013. Epub 2012 Jan 10.

7.

Inhibitor selectivity of a new class of oseltamivir analogs against viral neuraminidase over human neuraminidase enzymes.

Albohy A, Mohan S, Zheng RB, Pinto BM, Cairo CW.

Bioorg Med Chem. 2011 May 1;19(9):2817-22. doi: 10.1016/j.bmc.2011.03.039. Epub 2011 Mar 23.

PMID:
21489803
8.

Drugs against avian influenza a virus: design of novel sulfonate inhibitors of neuraminidase N1.

Udommaneethanakit T, Rungrotmongkol T, Frecer V, Seneci P, Miertus S, Bren U.

Curr Pharm Des. 2014;20(21):3478-87.

PMID:
24001233
9.

In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication.

Kati WM, Montgomery D, Carrick R, Gubareva L, Maring C, McDaniel K, Steffy K, Molla A, Hayden F, Kempf D, Kohlbrenner W.

Antimicrob Agents Chemother. 2002 Apr;46(4):1014-21.

10.

On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).

Mitrasinovic PM.

Biophys Chem. 2009 Mar;140(1-3):35-8. doi: 10.1016/j.bpc.2008.11.004. Epub 2008 Nov 20.

PMID:
19117662
11.

Combinatorial design of avian influenza neuraminidase inhibitors containing pyrrolidine core with a reduced susceptibility to viral drug resistance.

Rungrotmongkol T, Udommaneethanakit T, Frecer V, Miertus S.

Comb Chem High Throughput Screen. 2010 Mar;13(3):268-77.

PMID:
20015013
12.

Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.

Xie Y, Xu D, Huang B, Ma X, Qi W, Shi F, Liu X, Zhang Y, Xu W.

J Med Chem. 2014 Oct 23;57(20):8445-58. doi: 10.1021/jm500892k. Epub 2014 Oct 8.

PMID:
25255388
13.

Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities.

Sriwilaijaroen N, Wilairat P, Hiramatsu H, Takahashi T, Suzuki T, Ito M, Ito Y, Tashiro M, Suzuki Y.

Virol J. 2009 Aug 13;6:124. doi: 10.1186/1743-422X-6-124.

14.

Novel antiviral activity of neuraminidase inhibitors against an avian influenza a virus.

Ushirogawa H, Ohuchi M.

Virol J. 2011 Aug 19;8:411. doi: 10.1186/1743-422X-8-411.

15.

Replication inhibition activity of carbocycles related to oseltamivir on influenza A virus in vitro.

Niikura M, Bance N, Mohan S, Mario Pinto B.

Antiviral Res. 2011 Jun;90(3):160-3. doi: 10.1016/j.antiviral.2011.03.180. Epub 2011 Apr 2.

PMID:
21443905
16.

The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.

Ives JA, Carr JA, Mendel DB, Tai CY, Lambkin R, Kelly L, Oxford JS, Hayden FG, Roberts NA.

Antiviral Res. 2002 Aug;55(2):307-17.

PMID:
12103431
17.

Efficient synthesis of highly active phospha-isosteres of the influenza neuraminidase inhibitor oseltamivir.

Carbain B, Collins PJ, Callum L, Martin SR, Hay AJ, McCauley J, Streicher H.

ChemMedChem. 2009 Mar;4(3):335-7. doi: 10.1002/cmdc.200800379.

PMID:
19156651
18.

Molecular dynamics simulation of oseltamivir resistance in neuraminidase of avian influenza H5N1 virus.

Shu M, Lin Z, Zhang Y, Wu Y, Mei H, Jiang Y.

J Mol Model. 2011 Mar;17(3):587-92. doi: 10.1007/s00894-010-0757-x. Epub 2010 Jun 3.

PMID:
20517627
20.

Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes.

Abed Y, Nehmé B, Baz M, Boivin G.

Antiviral Res. 2008 Feb;77(2):163-6. Epub 2007 Sep 10.

PMID:
17919743

Supplemental Content

Support Center